// App-Quantinova.ai

2893 : Integration of Deep Multi-Omics Profiling Veals New Insights into the Biology of Poor-Risk Acute Myeloid Leukemia

Researchers

Presenter

  • Ana Rio-Machin

Principal Investigators

  • Juho Miettinen

  • Findlay Bewicke-Copley

  • Naeem Khan

  • Jonas Demeulemeester

  • Szilvia Krizsn

  • Jiexin Zheng

  • Christopher Middleton

  • Wencheng Yin

  • William Grey

  • Farideh Miraki-Moud

  • Janet Matthews

  • Marianne Grantham

  • Kevin Rouault-Pierre

  • Krister Wennerberg

  • Alun Parsons

  • Hannah Armes

  • Karina EM Close

  • Doriana Di Bella

  • James Cavenagh

  • Sylvie D Freeman

  • Peter Van Loo

  • Csaba Bodor

  • Kimmo Porkka

  • Caroline A Heckman

  • Jun Wang

  • David Taussig

  • Dominique Bonnet

  • Jean-Baptiste Cazier

  • Pedro Cutillas

  • Jude Fitzgibbon

Medical Centers

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

  • Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

  • Francis Crick Institute, London

  • MTA-SE Momentum Molecular Oncohematology Research Group, First Department of Pathology and Experimental Cancer Research,Semmelweis University,Budapest,Hungary

  • The Francis Crick Institute, London, United Kingdom

  • Institute for Cancer Research, London, United Kingdom

  • Barts Health NHS Trust, LONDON, GBR

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark

  • Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

  • Division of Haemato-Oncology, St Bartholomews Hospital, Barts Health NHS Trust, London, United Kingdom

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Semmelweis University, Budapest, Hungary

  • University of Helsinki, H, Finland

  • Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • NCRI, London, United Kingdom

  • Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Queen Mary University of London, London, United Kingdom

Locations

  • United Kingdom

  • Finland

  • Hungary

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved